Neuralstem (CUR) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-15.68M
Depreciation and amortization	275.07K
Share based compensation expenses	2.87M
Warrant issuance and modification expense
(Gain)/loss from change in fair value adjustment of warrant obligations
Prepaid expenses	212.57K
Other current assets
Other assets
Accounts payable and accrued expenses	1.03M
Accrued bonus expense	-161.36K
Net cash used in operating activities
Investment in intangible assets	-30.18K
Purchase of property and equipment	-98.09K
Net cash used in investing activities
Proceeds from issuance of common stock from warrants exercised
Issuance of common stock from private placement
Net cash provided by financing activities
Net (decrease)increase in cash and cash equivalents	959.6K
Cash and cash equivalents, beginning of period	4.72M
Cash and cash equivalents, end of period	5.68M
Cash paid for interest	869.04K
Cash paid for income taxes
Extinguishment of warrant obligations through exercise, expiration and modification of common stock warrants
Issuance of common stock for executive bonuses
Payment of services through common stock issuance	8.94K

Entities mentioned with CUR

View All Entities